Feasibility, acceptability and safety of personalized adaptive enzalutamide therapy in people with metastatic castrate-resistant prostate cancer (mCRPC): EnzAdapt

Craig Gedye, Jennifer McFarlane, Sarah Zardawi, Saba Kugashiya, Jaishree Jalewa,Sang Kim,James Lynam,Girish Mallesara, Howard Chan,Hiren Mandaliya, Ted Livshin,Tony Bonaventura, Patrick Skippen, Jessica Aldcroft, Kim Adler

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要